<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02505763</url>
  </required_header>
  <id_info>
    <org_study_id>14 7418 15</org_study_id>
    <nct_id>NCT02505763</nct_id>
  </id_info>
  <brief_title>Thoracic Ultrasound in the Treatment of Pleural Effusion</brief_title>
  <acronym>ECHOPLEV</acronym>
  <official_title>Treatment of Pleural Effusion by Routine Thoracic Ultrasound</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the study is to assess the cost-effectiveness ratio of two management
      strategies of pleurisy in adults : a strategy by systematic thoracic ultrasound versus a
      strategy without thoracic ultrasound.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparison of two management strategies pleural effusions from diagnosis and during the first
      year of follow up care.

      Patients are randomized into two groups, each group receiving a different management
      strategy.

      Both strategies are compared:

      Strategy A that involves the systematic use of thoracic ultrasound for the treatment of
      pleural effusion, treatment and follow up care. It will be possible to have recourse to other
      tests (such as chest CT) if deemed necessary by the practitioner.

      Strategy B, which consists of the usual care pleurisy and thus without use of ultrasound:
      gestures are guided either by chest radiograph or by CT chest as necessary in the treatment
      and monitoring. A systematic radiographic pleural after each gesture is performed.

      The management is inspired by the English recommendations currently validated and applied in
      Anglo-Saxon countries.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The cost-effectiveness ration</measure>
    <time_frame>1 year</time_frame>
    <description>Cost estimates will be conducted from the perspective of health insurance. The expenses incurred in the care of patients with pleurisy will be counted in both groups during the follow-up year.
The effectiveness will be assessed against the complications of strategy (pneumothorax, respiratory sequelae, surgery, mortality, chest pain sequelae, radiological consequences).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The duration of hospitalization</measure>
    <time_frame>1 year</time_frame>
    <description>number of day of hospitalization between the two strategies</description>
  </secondary_outcome>
  <other_outcome>
    <measure>The irradiation rate</measure>
    <time_frame>1 year</time_frame>
    <description>calculation of irradiation rate between the two strategies</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of consultations</measure>
    <time_frame>1 year</time_frame>
    <description>The number of consultations between the two strategies</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Pleural Effusion</condition>
  <arm_group>
    <arm_group_label>Strategy with thoracic ultrasound</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of thoracic ultrasound for the treatment of pleural effusion, treatment and monitoring.
Use of other examinations like chest CT if necessary</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Strategy without thoracic ultrasound</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care : without thoracic ultrasound
Use of chest radiography or chest CT scan if necessary, as for treatment and monitoring.
Usual care: without the use of ultrasound Using either chest radiography or TDM if necessary, as for treatment and monitoring.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Strategy with thoracic ultrasound</intervention_name>
    <description>This strategy involves the systematic use of thoracic ultrasound for the treatment of pleural effusion, treatment and follow up care.</description>
    <arm_group_label>Strategy with thoracic ultrasound</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients hospitalized or seen in consultation with pleural effusion diagnosed
             clinically or radiologically whatever be its initial management.

        Exclusion Criteria:

          -  Patient with a neoplasia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elise NOEL-SAVINA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elise NOEL-SAVINA, MD</last_name>
    <phone>0567771691</phone>
    <phone_ext>+33</phone_ext>
    <email>noel-savina.e@chu-toulouse.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alain DIDIER, Professor</last_name>
    <phone>0567771830</phone>
    <phone_ext>+33</phone_ext>
    <email>didier.a@chu-toulouse.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NOEL-SAVINA Elise</name>
      <address>
        <city>Toulouse</city>
        <state>Midi Pyrenees</state>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elise NOEL-SAVINA, MD</last_name>
      <phone>0567771691</phone>
      <phone_ext>+33</phone_ext>
      <email>noel-savina.e@chu-toulouse.fr</email>
    </contact>
    <contact_backup>
      <last_name>Alain DIDIER, MD</last_name>
      <phone>0567771830</phone>
      <phone_ext>+33</phone_ext>
      <email>didier.a@chu-toulouse.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Elise NOEL-SAVINA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alain DIDIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gavin PLAT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandrine PONTIER-MARCHANDISE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Havelock T, Teoh R, Laws D, Gleeson F; BTS Pleural Disease Guideline Group. Pleural procedures and thoracic ultrasound: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010 Aug;65 Suppl 2:ii61-76. doi: 10.1136/thx.2010.137026.</citation>
    <PMID>20696688</PMID>
  </reference>
  <reference>
    <citation>Reissig A, Copetti R, Mathis G, Mempel C, Schuler A, Zechner P, Aliberti S, Neumann R, Kroegel C, Hoyer H. Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia: a prospective, multicenter, diagnostic accuracy study. Chest. 2012 Oct;142(4):965-972. doi: 10.1378/chest.12-0364.</citation>
    <PMID>22700780</PMID>
  </reference>
  <reference>
    <citation>Jones PW, Moyers JP, Rogers JT, Rodriguez RM, Lee YC, Light RW. Ultrasound-guided thoracentesis: is it a safer method? Chest. 2003 Feb;123(2):418-23.</citation>
    <PMID>12576360</PMID>
  </reference>
  <reference>
    <citation>Ikezoe J, Morimoto S, Arisawa J, Takashima S, Kozuka T, Nakahara K. Percutaneous biopsy of thoracic lesions: value of sonography for needle guidance. AJR Am J Roentgenol. 1990 Jun;154(6):1181-5.</citation>
    <PMID>2110724</PMID>
  </reference>
  <reference>
    <citation>Chen HJ, Yu YH, Tu CY, Chen CH, Hsia TC, Tsai KD, Shih CM, Hsu WH. Ultrasound in peripheral pulmonary air-fluid lesions. Color Doppler imaging as an aid in differentiating empyema and abscess. Chest. 2009 Jun;135(6):1426-1432. doi: 10.1378/chest.08-2188. Epub 2009 Mar 2.</citation>
    <PMID>19255298</PMID>
  </reference>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 21, 2015</study_first_submitted>
  <study_first_submitted_qc>July 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2015</study_first_posted>
  <last_update_submitted>July 21, 2015</last_update_submitted>
  <last_update_submitted_qc>July 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pleural Effusion</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

